Alexander M. Stessin, MD, PhD

I am a radiation oncologist at Stony Brook University Hospital where I also serve as the Radiation Oncology Residency Program Director. My primary subspecialty areas include breast cancer, cancers of the gastrointestinal tract, pediatric malignancies, and tumors of the central nervous system.

Over the past decade I have had the unique privilege of being part of a multidisciplinary team of physicians providing cutting edge cancer care here at Stony Brook. I have been involved in translational research studies and have successfully launched several investigator-initiated clinical trials. It has been immensely gratifying to see our laboratory discoveries make their way into clinical practice in a true spirit of "bench-to-bedside". As well, I am honored to be able to care for my patients alongside the most qualified and dedicated group of colleagues. I believe that the level of personalized care which we are able to offer, based on the latest technological and scientific advances in oncology, is second to none, and our shared passion for fighting cancer is what defines who we are as an institution.

• Myoepithelial Carcinoma: The Role of Radiation Therapy. A Case Report and Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry.
  
  Miccio JA | Oladeru OT | Yang J | Xue Y | Hoda ST | Ryu S | Stessin AM | Parker RI
  Journal of pediatric hematology/oncology
  2016 Feb 15
  
  
• Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis.
  
  Chen JJ | Stessin A | Christos P | Wernicke AG | Nori D | Parashar B
  The Laryngoscope
  2015 Sep
  
  
• Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015.
  
  Ryu S | Yoon H | Stessin A | Gutman F | Rosiello A | Davis R
  Radiation oncology journal
  2015 Mar
  
  
• Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
  
  Martinez J | Stessin AM | Campana A | Hou J | Nikulina E | Buck J | Levin LR | Filbin MT
  The Journal of neuroscience : the official journal of the Society for Neuroscience
  2014 Jul 9
  
  
• Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database.
  
  Stessin AM | Sison C | Schwartz A | Ng J | Chao CK | Li B
  Cancer
  2014 Nov 15
  
  
• The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database.
  
  Stessin AM | Sison C | Nieto J | Raifu M | Li B
  International journal of radiation oncology, biology, physics
  2013 Mar 1
  
  
• Comparing the rates of urinary tract infections among patients receiving adjuvant pelvic intensity modulated radiation therapy, 3-dimensional conformal radiation therapy, and brachytherapy for newly diagnosed endometrial cancer.
  
  Boothe D | Patel SH | Stessin A | Parashar B | Nori D | Wernicke AG
  Practical radiation oncology
  2013 Oct-Dec
  
  
• FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
  
  Stessin AM | Gursel DB | Schwartz A | Parashar B | Kulidzhanov FG | Sabbas AM | Boockvar J | Nori D | Wernicke AG
  Neuroscience letters
  2012 May 16
  
  
• Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
  
  Stessin AM | Schwartz A | Judanin G | Pannullo SC | Boockvar JA | Schwartz TH | Stieg PE | Wernicke AG
  Journal of neurosurgery
  2012 Oct
  
  
• Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma.
  
  Stessin AM | Sherr DL
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  2011 Feb
  
  
• Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
  
  Stessin AM | Meyer JE | Sherr DL
  International journal of radiation oncology, biology, physics
  2008 Nov 15
  
  
• Soluble adenylyl cyclase-generated cyclic adenosine monophosphate promotes fast migration in PC12 cells.
  
  Young JJ | Mehdi A | Stohl LL | Levin LR | Buck J | Wagner JA | Stessin AM
  Journal of neuroscience research
  2008 Jan
  
  
• Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.
  
  Stessin AM | Zippin JH | Kamenetsky M | Hess KC | Buck J | Levin LR
  The Journal of biological chemistry
  2006 Jun 23
  
  
• Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils.
  
  Han H | Stessin A | Roberts J | Hess K | Gautam N | Kamenetsky M | Lou O | Hyde E | Nathan N | Muller WA | Buck J | Levin LR | Nathan C
  The Journal of experimental medicine
  2005 Aug 1